Cryotherapy developer Oncura introduced several enhancements to its prostate cancer cryotherapy technology at this month's American Urological Association meeting in San Francisco. Oncura is an independent business of Amersham, which was acquired by Waukesha, WI-based GE Healthcare in April.
The innovations include an increase in the size of the therapeutic ice ball generated by the firm's IceRod 17-gauge CryoNeedle, a new workstation, and other enhancements aimed at shortening the time required to perform prostate-cancer cryotherapy, Oncura said.
By AuntMinnie.com staff writersMay 20, 2004
Related Reading
Point/counterpoint: Prostate cancer researchers battle over treatment options, May 14, 2004
GE inks Italian RIS/PACS deal, May 4, 2004
GE Healthcare's Q1 sales, earnings grow, April 9, 2004
GE closes acquisition of Amersham, April 8, 2004
Copyright © 2004 AuntMinnie.com